NCT02773641View on ClinicalTrials.gov

Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Vulvodynia
Interventions
DRUG

Botulinum Toxin Type A

DRUG

Sterile Saline Solution

Trial Locations (1)

182 88

Danderyd Hospital, Dep. of Obstetrics and Gynecology, Stockholm

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT02773641 - Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia | Biotech Hunter | Biotech Hunter